MedPath

Organ Dysfunction Changes in Acute Necrotizing Pancreatitis Patients With Sepsis Following Open Necrosectomy

Not yet recruiting
Conditions
Necrotizing Pancreatitis
Registration Number
NCT07201246
Lead Sponsor
West China Hospital
Brief Summary

The purpose of this retrospective study was to characterize the changes in organ dysfunction among patients with acute necrotizing pancreatitis complicated by sepsis who underwent open necrosectomy.

Detailed Description

Baseline demographic and clinical characteristics (including age, gender, and education level) were collected from medical records. Organ dysfunction was defined according to the Sequential Organ Failure Assessment (SOFA) score. SOFA scores were extracted at predefined time points: preoperative (T1), postoperative day 1 (T2), postoperative day 3 (T3), and either postoperative day 7 or hospital discharge, whichever occurred first (T4). Postoperative survival status up to 1 year was obtained from the institutional database.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
700
Inclusion Criteria
  1. Patients 18 years or older
  2. Diagnosis of Acute pancreatitis according to the revised Atlanta classification, requires two of thefollowing three criteria: (A) typical abdominal pain, (B) an increase in serum amylase or lipaselevels higher than three times the upper limit of normality, and (C) signs of AP in imaging3)Patients with confirmed or suspected infected pancreatic or peripancreatic necrosis werescheduled for open necrosectomy
  3. Meet Sepsis-3 criteria
Exclusion Criteria

Patients undergo repeat surgery on the same site

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measure organ dysfunction change after open necrosectomy with respect to timeup to postoperative day 7, or at hospital discharge, whichever comes first

Organ dysfunction was assessed retrospectively using the Sequential Organ Failure Assessment (SOFA) score, which ranges from 0 (normal) to 4 (most abnormal) for each organ, with higher scores indicating more severe dysfunction.

Secondary Outcome Measures
NameTimeMethod
Incidence of ICU mortalityan average of 1year
Incidence of 28-day mortalityan average of 1 year
ICU length of hospital stayan average of 1 year
Incidence of hospital mortalityan average of 1 year
Incidence of one year mortalityan average of 1 year
Length of hospital stayan average of 1 year

Trial Locations

Locations (1)

West China Hospital, Sichuan University

🇨🇳

Chengdu, China, China

West China Hospital, Sichuan University
🇨🇳Chengdu, China, China
Fengming Luo, PhD
Contact
02885423593
jiangchunling@scu.edu.cn

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.